Judith A.M. Wessels

2.6k total citations
43 papers, 2.0k citations indexed

About

Judith A.M. Wessels is a scholar working on Pharmacology, Rheumatology and Hematology. According to data from OpenAlex, Judith A.M. Wessels has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 11 papers in Rheumatology and 9 papers in Hematology. Recurrent topics in Judith A.M. Wessels's work include Pharmacogenetics and Drug Metabolism (13 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Acute Lymphoblastic Leukemia research (7 papers). Judith A.M. Wessels is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Rheumatoid Arthritis Research and Therapies (11 papers) and Acute Lymphoblastic Leukemia research (7 papers). Judith A.M. Wessels collaborates with scholars based in Netherlands, China and United States. Judith A.M. Wessels's co-authors include Henk‐Jan Guchelaar, T. Huizinga, Cornelia F Allaart, Hans Gelderblom, Tahar van der Straaten, Saskia le Cessie, Ron H.J. Mathijssen, John B.A.G. Haanen, Karel Eechoute and Nielka P. van Erp and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Neurology and Clinical Cancer Research.

In The Last Decade

Judith A.M. Wessels

43 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judith A.M. Wessels Netherlands	23	655	446	406	370	339	43	2.0k
Eduardo Mysler United States	32	3.5k 5.3×	448 1.0×	1.0k 2.6×	112 0.3×	552 1.6×	106	5.8k
Shigeru Horita Japan	29	124 0.2×	616 1.4×	219 0.5×	223 0.6×	106 0.3×	123	2.7k
Lija Joseph United States	25	279 0.4×	890 2.0×	313 0.8×	130 0.4×	125 0.4×	44	2.5k
H. Terence Cook United Kingdom	34	566 0.9×	457 1.0×	255 0.6×	50 0.1×	171 0.5×	68	2.5k
Donatella Colaizzo Italy	28	306 0.5×	283 0.6×	1.3k 3.1×	112 0.3×	294 0.9×	84	2.5k
Hilary A. Capell United Kingdom	10	1.9k 2.9×	280 0.6×	582 1.4×	57 0.2×	264 0.8×	22	2.6k
Mario Bargetzi Switzerland	26	69 0.1×	324 0.7×	747 1.8×	232 0.6×	425 1.3×	91	2.3k
Young Hee Rho South Korea	28	1.1k 1.6×	420 0.9×	195 0.5×	56 0.2×	111 0.3×	49	2.5k
Jay Garg United States	15	1.4k 2.1×	147 0.3×	144 0.4×	67 0.2×	218 0.6×	42	2.6k
Doyeun Oh South Korea	28	179 0.3×	624 1.4×	389 1.0×	102 0.3×	223 0.7×	103	2.2k

Countries citing papers authored by Judith A.M. Wessels

Since Specialization

Citations

This map shows the geographic impact of Judith A.M. Wessels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith A.M. Wessels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith A.M. Wessels more than expected).

Fields of papers citing papers by Judith A.M. Wessels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith A.M. Wessels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith A.M. Wessels. The network helps show where Judith A.M. Wessels may publish in the future.

Co-authorship network of co-authors of Judith A.M. Wessels

This figure shows the co-authorship network connecting the top 25 collaborators of Judith A.M. Wessels. A scholar is included among the top collaborators of Judith A.M. Wessels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith A.M. Wessels. Judith A.M. Wessels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Swen, Jesse J., Judith A.M. Wessels, Tahar van der Straaten, et al.. (2013). Exploratory analysis of 1,936 SNPs in ADME genes for association with busulfan clearance in adult hematopoietic stem cell recipients. 4. 2 indexed citations

Schie, Rianne MF van, Talitha I. Verhoef, Tom Schalekamp, et al.. (2012). Evaluation of the effect of statin use on the acenocoumarol and phenprocoumon maintenance dose. Drug metabolism and drug interactions. 27(4). 229–234. 5 indexed citations

Verschuren, Jeffrey J. W., Judith A.M. Wessels, Stella Trompet, et al.. (2012). Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction. European Heart Journal. 33. 516–516. 3 indexed citations

Schie, Rianne MF van, Tom Schalekamp, Judith A.M. Wessels, et al.. (2012). An evaluation of gene–gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol. Journal of Thrombosis and Haemostasis. 10(5). 767–772. 13 indexed citations

Verschuren, Jeffrey J. W., Helèn Boden, Judith A.M. Wessels, et al.. (2012). Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction. International Journal of Cardiology. 167(6). 2882–2888. 29 indexed citations

Surh, Linda, Sabine Fürst‐Recktenwald, Achille Iolascon, et al.. (2011). Integration of Pharmacogenetics and Pharmacogenomics in Drug Development: Implications for Regulatory and Medical Decision Making in Pediatric Diseases. The Journal of Clinical Pharmacology. 52(5). 704–716. 13 indexed citations

Coenen, Marieke J. H., Judith A.M. Wessels, Sita H. Vermeulen, et al.. (2011). Genome-Wide Association Analysis of Rheumatoid Arthritis Patients Treated with Anti-TNF Medication. Data Archiving and Networked Services (DANS). 63(10). 1 indexed citations

Swen, Jesse J., Tahar van der Straaten, Judith A.M. Wessels, et al.. (2011). Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19. European Journal of Clinical Pharmacology. 68(4). 363–370. 30 indexed citations

Verschuren, Jeffrey J. W., Stella Trompet, Judith A.M. Wessels, et al.. (2011). A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?. European Heart Journal. 33(2). 165–175. 59 indexed citations

10.

Dervieux, Thierry, Judith A.M. Wessels, Joel M. Kremer, et al.. (2011). Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis. Pharmacogenetics and Genomics. 22(1). 1–9. 37 indexed citations

11.

Veldt, Astrid A.M. van der, Karel Eechoute, Hans Gelderblom, et al.. (2010). Genetic Polymorphisms Associated with a Prolonged Progression-Free Survival in Patients with Metastatic Renal Cell Cancer Treated with Sunitinib. Clinical Cancer Research. 17(3). 620–629. 127 indexed citations

12.

Pander, Jan, Judith A.M. Wessels, Hans Gelderblom, et al.. (2010). Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer. Annals of Oncology. 22(5). 1147–1153. 31 indexed citations

13.

Movig, Kris L. L., Toine C. G. Egberts, P.J.E. Poels, et al.. (2009). Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease. European Journal of Clinical Pharmacology. 65(12). 1245–1251. 26 indexed citations

14.

Wessels, Judith A.M., et al.. (2009). Criteria for the selection of single nucleotide polymorphisms in pathway pharmacogenetics: TNF inhibitors as a case study. Drug Discovery Today. 14(17-18). 837–844. 8 indexed citations

15.

Huizinga, T., et al.. (2009). Pharmacogenetics in Treatment of Rheumatoid Arthritis. Current Pharmaceutical Design. 16(2). 164–175. 28 indexed citations

16.

Steeghs, Neeltje, Hans Gelderblom, Judith A.M. Wessels, et al.. (2009). Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors. Investigational New Drugs. 29(1). 137–143. 18 indexed citations

17.

Wessels, Judith A.M., D. M. C. Brinkman, Lisette W. A. van Suijlekom‐Smit, et al.. (2008). Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Arthritis Care & Research. 61(1). 46–51. 100 indexed citations

18.

Wessels, Judith A.M., S M van der Kooij, Saskia le Cessie, et al.. (2007). A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent‐onset rheumatoid arthritis. Arthritis & Rheumatism. 56(6). 1765–1775. 187 indexed citations

19.

Wesoły, Joanna, Judith A.M. Wessels, Henk‐Jan Guchelaar, & T. Huizinga. (2006). Genetic markers of treatment response in rheumatoid arthritis. Current Rheumatology Reports. 8(5). 369–377. 10 indexed citations

20.

Badrising, Umesh A., Marion L. C. Maat–Schieman, Michel D. Ferrari, et al.. (2002). Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo. Annals of Neurology. 51(3). 369–372. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact